COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients -
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolébrutinib dans la sclérose en plaques secondaire progressive non-récurrente
Sanofi retarde la soumission réglementaire du tolébrutinib pour la SEPSPnr, attend des orientations supplémentaires de la FDA au premier trimestre 2026 -
COMMUNIQUÉ DE PRESSE
All for One Group SE confirms preliminary figures for 2024/25 financial year // Stable distribution policy // Forecast confirmed
All for One Group SE confirms preliminary figures for 2024/25 financial year with stable distribution policy and confirmed forecast. Revenue at EUR 503.7 million, EBIT margin at 5.2% -
-
-
-
-
-
